Agios Pharmaceuticals, Inc. (AGIO) Profit Margins
Over the twelve months to 2026-06-30, Agios Pharmaceuticals, Inc. (AGIO) had gross margin 92.0%, operating margin -466.8%, net margin -418.2%, free cash flow margin -371.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AGIOAgios Pharmaceuticals, Inc.Follow AGIO — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | 98.5% | 98.9% | 88.0% | 89.3% | 88.6% | 88.3% | 92.0% | |
| Operating margin | -152.2% | -82.8% | -200.8% | -287.6% | -745.8% | -384.0% | -268.2% | -2732.1% | -1459.5% | -1166.5% | -873.9% | -466.8% | |
| Net margin | -154.2% | -81.9% | -199.1% | -284.0% | -731.6% | -366.6% | -349.0% | -1627.8% | -1312.6% | 1845.9% | -764.0% | -418.2% | |
| FCF margin | -225.8% | -94.2% | -164.3% | 41.0% | -673.9% | -329.9% | -324.5% | -2207.6% | -1107.5% | -1072.7% | -698.3% | -371.4% |
USD billions · SEC XBRL
Agios Pharmaceuticals, Inc. — questions
- What is Agios Pharmaceuticals, Inc.'s gross margin?
- 92.0% over the twelve months to 2026-06-30.
- What is Agios Pharmaceuticals, Inc.'s operating margin?
- -466.8% over the twelve months to 2026-06-30.
- What is Agios Pharmaceuticals, Inc.'s net profit margin?
- -418.2% over the twelve months to 2026-06-30.
Every figure on this page comes from Agios Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.